a highly motivated and passionate neuroscientist with seven years of Pharmaceutical and academic experience focused on unraveling the Pathophysiology of neurodegenerative diseases, including alzheimer`s disease and x-linked adrenoleukodystrophy. broad interest in neurodegenerative disorders ranging from target identification and Validation studies to early proof of concept Clinical designs. an extensive knowledge of molecular, cellular and functional neurobiology specific to neurological disorders. in addition, expertise in a variety of other necessary skills, including: - ability to plan, critique, execute and follow up on experimental studies - well organized and efficient in conducting experiments under tight deadlines - highly skilled in compiling study reports and presenting data - goal-driven and detail oriented - team player, able to connect and work alongside multi-disciplinary Research/scientific teams and professionals - high capability to participate in and lead high-level scientific and strategic discussions - robust Problem Solving skills for the development of creative solutions for project based issues - demonstrated influencing, Negotiation and conflict resolution skills, including the ability to influence without clear reporting authorities
POST-DOCTORAL SCIENTIST, NEUROSCIENCE DRUG DISCOVERY: IMMUNOPET PROJECT AT JANSSEN PHARMACEUTICA NV
Since June 2012
primary collaborator on the iwt funded ‘immuno-positron emission tomography (pet) imaging’ project for the development of novel antibody imaging tools for the potential diagnosis and Treatment response in alzheimer’s disease. project responsibilities include the optimization of Immunohistochemistry Assays for in-vitro/vivo Characterization of novel Antibodies targeting specific epitopes of beta-amyloid or tau. data key for identification of Antibodies suitable for radioactive labeling at University of antwerp (mica). Primary collaborator on the IWT funded ‘Immuno-Positron Emission Tomography (PET) imaging’ project for the development of novel antibody imaging tools for the potential diagnosis and treatment response in Alzheimer’s disease. Project responsibilities include the optimization of immunohistochemistry assays for in-vitro/vivo characterization of novel antibodies targeting specific epitopes of beta-amyloid or Tau. Data key for identification of antibodies suitable for radioactive labeling at University of Antwerp (MICA).
PHD: THE ROLE OF PEROXISOMES IN THE FORMATION AND MAINTENANCE OF MYELINATED AXONS.September 2007 --- November 2012
investigation of the pathophysiological mechanisms leading to neurological deficits in transgenic mouse models of peroxisomal dysfunction. acquired significant expertise in immunohistochemical and confocal and electron Microscopy techniques. additional techniques acquired include Quantitative PCR, Western Blotting, isolation of myelin and lipid raft micro-domains and neuronal Cell culturing techniques. collaborations have provided me with a rudimentary understanding of HPLC and gas chromatography Mass Spectrometry Analysis.
LinkedIn Assessment :
in Getting the most of your confocal microscope from University of York in 2010
3rd Bachelor in Pharmaceutical sciences from University of Louvain in 2006
Master in Biomedical sciences from University of Antwerp in 2005
Bachelor's degree in Biomedical sciences from University of Hasselt in 2003
in Latin-mathematics from Don Boscocollege Hechtel in 2001
Area / Region